TY  - JOUR
T1  - UPdate on influenza a (h1n1) 2009 monovalent vaccines
Y1  - 2009/11/18
N1  - 
JO  - JAMA
SP  - 2084
EP  - 2085
VL  - 302
IS  - 19
N2  - 
On September 15, 2009, four influenza vaccine manufacturers received approval from the Food and Drug Administration for use of influenza A (H1N1) 2009 monovalent influenza vaccines in the prevention of influenza caused by the 2009 pandemic influenza A (H1N1) virus.* Both live, attenuated and inactivated influenza A (H1N1) 2009 monovalent vaccine formulations are available; each contains the strain A/California/7/2009(H1N1)pdm. None of the approved influenza A 2009 (H1N1) monovalent vaccines or seasonal influenza vaccines contains adjuvants.1-5 CDC's Advisory Committee on Immunization Practices has made recommendations previously for which persons should be the initial targets for immunization with influenza A (H1N1) 2009 monovalent vaccines and has issued guidelines on decisions for expansion of vaccination efforts to other population groups.6 Children aged 6 months–9 years receiving influenza A (H1N1) 2009 monovalent vaccines should receive 2 doses, with doses separated by approximately 4 weeks; persons aged ≥10 years should receive 1 dose.1-4

SN  - 0098-7484
M3  - doi: 
UR  - http://dx.doi.org/
ER  -